Immunovia AB Stock London S.E.
Stocks
0G8X
SE0006091997
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
After hours 18:25:00 | |||
| 31.92 SEK | -32.03% |
|
0.1820 | -99.43% |
| 04:03pm | Calendar Thursday, August 6 | FW |
| 06-15 | Immunovia Unveils New Data Ahead of Medicare Reimbursement Application | FW |
| Market Cap | 122M 12.9M 11.18M 10.42M 9.58M 18.09M 1.23B 18.29M 48.05M 614M 48.46M 47.4M 2.03B | P/E 2026 * |
-1.8x | P/E 2027 * | -4.49x |
|---|---|---|---|---|---|
| Enterprise Value | 55.43M 5.84M 5.06M 4.72M 4.34M 8.19M 555M 8.28M 21.75M 278M 21.94M 21.46M 921M | EV / Sales 2026 * |
17.3x | EV / Sales 2027 * | 2.8x |
| Free-Float |
89.3% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Immunovia AB
| 1 day | -32.03% | ||
| 1 week | +18,036.36% | ||
| Current month | +17,812.46% | ||
| 1 month | +16,370.59% | ||
| 3 months | +15,604.80% | ||
| 6 months | +15,860.00% | ||
| Current year | +13,658.62% |
| 1 month | 0.18 |  | 0.32 |
| Current year | 0.15 | | 0.32 |
| 1 year | 0.15 | | 0.92 |
| 3 years | 0.15 | | 2.78 |
| 5 years | 0.15 | | 139.14 |
| 10 years | 0.15 | | 292 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeff Borcherding
CEO | Chief Executive Officer | 53 | 29/04/2023 |
Lisa Ford
CTO | Chief Tech/Sci/R&D Officer | 55 | 29/04/2024 |
| Chief Tech/Sci/R&D Officer | 54 | 31/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 72 | 09/12/2016 | |
Peter Andersen
CHM | Chairman | 69 | 26/05/2023 |
| Director/Board Member | 51 | 01/01/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -32.03% | +18,036.36% | - | - | 12.66M | |
| +0.57% | +2.92% | +27.38% | -37.12% | 16.4B | |
| -0.51% | +4.36% | +6.50% | +114.13% | 1.83B | |
| -0.48% | +6.03% | -26.12% | -79.15% | 1.2B | |
| -0.22% | -0.44% | -34.37% | +22.50% | 984M | |
| -0.98% | +4.12% | -45.91% | -52.09% | 668M | |
| -2.01% | +3.27% | -47.59% | -52.01% | 547M | |
| +0.16% | +13.15% | +78.02% | -45.44% | 521M | |
| -0.16% | +3.23% | -50.19% | -46.62% | 393M | |
| -0.40% | +2.63% | -12.93% | -28.06% | 372M | |
| Average | -3.56% | +3.78% | -11.69% | -22.65% | 2.55B | |
| Weighted average by Cap. | +0.20% | +2.95% | +15.50% | -25.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.2M 337K 292K 272K 250K 473K 32.07M 478K 1.26M 16.05M 1.27M 1.24M 53.15M | 17.3M 1.82M 1.58M 1.47M 1.35M 2.56M 173M 2.58M 6.79M 86.75M 6.85M 6.7M 287M |
| Net income | -91M -9.59M -8.31M -7.74M -7.12M -13.45M -912M -13.6M -35.72M -456M -36.02M -35.23M -1.51B | -82M -8.64M -7.49M -6.98M -6.42M -12.12M -822M -12.25M -32.18M -411M -32.46M -31.75M -1.36B |
| Net Debt | -67M -7.06M -6.12M -5.7M -5.24M -9.9M -672M -10.01M -26.3M -336M -26.52M -25.94M -1.11B | -74M -7.8M -6.76M -6.3M -5.79M -10.93M -742M -11.06M -29.04M -371M -29.29M -28.65M -1.23B |
Employees
17
Calendar
| Date | Price | Change | Volume |
|---|
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IMMNOV Stock
- 0G8X Stock
Select your edition
All financial news and data tailored to specific country editions
